Full-Time
Head of Systematic Trading Infrastructure
Posted on 9/17/2025
Point72
201-500 employees
Global asset manager for long/short equity
Compensation Overview
$275k - $350k/yr
Company Historically Provides H1B Sponsorship
United States
In Person
 Quantitative Finance (1) |
|---|
- 10+ years of experience in platform engineering, infrastructure, or runtime environments, with at least 5 years in leadership roles.
- Demonstrated success in managing large-scale, distributed runtime platforms in cloud and hybrid environments.
- Experience in regulated industries (e.g., finance, healthcare).
- Deep expertise in container orchestration platforms (e.g., Kubernetes, Nomad, OpenShift) and runtime environments.
- Strong knowledge of cloud-native architecture, microservices, and serverless platforms.
- Experience with monitoring and observability tools (e.g., Prometheus, Grafana, Datadog) for runtime platforms.
- Proven ability to optimize runtime environments for performance, scalability, and cost efficiency.
- Commitment to the highest ethical standards.
- Build, lead, and mentor a team of infrastructure engineers, fostering a culture of innovation, collaboration, and excellence.
- Define team goals and priorities, ensuring alignment with the firm’s systematic trading strategy and broader business objectives.
- Provide clear direction, guidance, and support to team members, enabling them to excel in their roles and grow professionally.
- Promote cross-functional collaboration with trading teams, quantitative researchers, and application developers to ensure infrastructure solutions meet business needs.
- Act as a trusted advisor to senior leadership, providing insights and recommendations on infrastructure strategy and investments.
- Develop and execute a strategic roadmap for systematic trading infrastructure, ensuring scalability, reliability, and low-latency performance.
- Evaluate emerging technologies and industry trends to identify opportunities for innovation and competitive advantage.
- Oversee infrastructure operations across colocation sites globally, ensuring optimal performance and uptime.
- Manage vendor relationships and negotiate contracts to ensure access to cutting-edge hardware and software solutions.
- Provide high-level oversight of Linux systems, network platforms, and storage solutions, ensuring they are optimized for low-latency trading.
- Ensure infrastructure at colocation sites is designed and maintained to meet the unique demands of high-frequency trading.
- Drive automation initiatives to improve efficiency and scalability across infrastructure operations.
- Implement robust monitoring and troubleshooting processes to proactively identify and resolve performance bottlenecks.
- Partner with Compliance to ensure infrastructure complies with regulatory requirements and internal policies related to data security, reliability, and operational risk.
- Develop and enforce best practices for infrastructure management, including disaster recovery and business continuity planning.
Point72 is a global asset management firm offering discretionary long/short equity, systematic, and macro investing, with a growing private markets portfolio. Its products combine active fund management with model-driven approaches across assets and geographies, earning money through management fees and performance-based incentives. The firm differentiates itself through a mix of discretionary trading, systematic methods, macro-focused strategies, a global footprint, and a commitment to ESG practices under Steven A. Cohen. Its goal is to generate superior returns for clients, grow assets, and maintain a culture centered on excellence and continuous learning.
Company Size
201-500
Company Stage
Private
Total Funding
$5.2B
Headquarters
Stamford, Connecticut
Founded
2014
Simplify's Take
What believers are saying
- $89.4B portfolio with NVIDIA, TSM drives AI hardware alpha generation.
- 59,746 sq ft Hudson Yards lease attracts top quant talent.
- Private investments yield proprietary insights beyond public markets.
What critics are saying
- NVIDIA concentration loses 30% on AI cooldown by Q4 2026.
- SEC fines $500M for insider trading in systematic strategies 2027.
- Citadel poaches 20% quants, eroding macro edge by Q3 2026.
What makes Point72 unique
- Point72 Turion invests in SiFive's $400M RISC-V round with NVIDIA.
- Point72 leads $60M PIPE for Ovid Therapeutics' OV329 GABA inhibitor.
- Point72 Ventures targets fintech, AI, and enterprise startups exclusively.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Point72 who can refer or advise you
Benefits
Fully-paid health care benefits
Generous parental and family leave policies
Mental and physical wellness programs
Volunteer opportunities
Non-profit matching gift program
Support for employee-led affinity groups representing women, minorities and the LGBT+ community
Tuition assistance
A 401(k) savings program with an employer match and more
Company News
Several major hedge funds are reducing their investment staff in Miami despite the city's reputation as a growing finance hub. Eight multistrategy firms — including Citadel, Millennium, Point72 and Balyasny — employed 218 investment professionals in Miami in 2025, down 20 from the previous year, even as their overall investing head count grew by over 11%. Citadel, which moved its headquarters to Miami in 2022, cut 15 investment professionals there whilst adding 77 globally. Millennium reduced its Miami presence from 53 investors to 48 and consolidated from two offices to one. Only ExodusPoint and Walleye increased their Miami investment staff. Growth is instead concentrated in New York, London, Hong Kong and Dubai, according to regulatory filings.
Point72 inks lease at Tishman Speyer's Hudson Yards office. Steve Cohen's Point72 Asset Management is significantly growing its footprint in Hudson Yards with a new lease at The Spiral. According to sources familiar with the transaction, the global alternative investment firm has secured 59,746 square feet of office space in Manhattan, N.Y., within Tishman Speyer's 66-story tower located at 66 Hudson Blvd. This expansion covers the entire 31st floor and a portion of the 21st floor. While the duration of the agreement was not disclosed, the starting rent was reported at $130 per square foot. Although the deal was finalized in December, it was previously unreported until now. In this transaction, Point72 was represented by Neil Goldmacher, Brian Goldman, and Michael Horn of Newmark, while Tishman Speyer was represented in-house by Samantha Augarten and Sam Brodsky. Both firms declined to comment on the specifics of the deal. This move represents a strategic expansion within the immediate neighborhood for Point72, which already maintains a massive presence nearby at 55 Hudson Yards. Before consolidating its operations in this district, Cohen's company occupied 11 floors across two separate buildings at 330 and 510 Madison Ave. Since then, the firm has leased more than 175,000 square feet in the tower that was developed by Related Companies, Oxford Properties Group and Mitsui Fudosan America. With this deal, The Spiral - a 2.85-million-square-foot skyscraper designed by the Bjarke Ingels Group - has reached 98% occupancy. This follows a late 2024 move by private equity giant TPG, which took 301,000 square feet across eight high-rise floors. The building also hosts the U.S. headquarters of HSBC, as well as the likes of Pfizer; Turner Construction; Debevoise & Plimpton LLP; AllianceBernstein; and Marshall Wace. The tower originally opened in 2023. It's situated diagonally across West 34th Street and Bella Abzug Park near the firm's other offices at 55 Hudson Yards. The location also provides a personal convenience for Cohen: With the 7 subway line terminating at Bella Abzug Park, the new lease at The Spiral offers a direct transit route to Citi Field. This connection is timely because Cohen's $8 billion Metropolitan Park proposal was one of three to receive a state gaming license at the end of last year. In partnership with Hard Rock International, Cohen intends to transform 50 acres of parking lots adjacent to the Mets' stadium into a sprawling casino complex. The planned facility includes nearly 300,000 square feet of gaming space; a 1,000-room hotel; a live music venue for 5,650 people; various restaurants; and 25 acres of dedicated green space. Senior Content Writer, CRE News & Market Analysis Drawing on years of intense research in the U.S. commercial real estate market at Yardi Matrix, Diana now applies her expertise as a writer for the CommercialCafe blog. Her articles focus on CRE investment, labor market trends, and technology, and have been picked up by prestigious publications including the New York Times, GlobeSt, The Real Deal, NAIOP, MSN, and Bisnow. March 24, 2026 March 23, 2026 March 20, 2026
Proceeds expected to support expansion of next-generation GABA-aminotransferase inhibitor, OV329, into tuberous sclerosis complex and infantile spasms Financing led by Point72 with participation from additional investors including Adage Capital Management, ADAR1 Capital Management, Affinity Asset Advisors, LLC, Ally Bridge Group, Balyasny Asset Management, Coastlands Capital, Eventide Asset Management, Janus Henderson Investors and RA Capital Management NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) - Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need, today announced that it has entered into a securities purchase agreement for a private investment in public equity (“PIPE”) financing that is expected to result in gross proceeds of $60.0 million to the Company, before placement agent fees and offering expenses. The PIPE financing is expected to close on or about March 19, 2026, subject to
Issam Bazzi, a senior leader at Cubist Systematic Strategies, Point72's quant division, is leaving after nearly three years at the $46 billion hedge fund. Bazzi helped lead the buildout of a centralised trading unit at Cubist but his team had been struggling, with losses reaching as much as $70 million this year. The departure follows a leadership shake-up at Cubist last September, when president Denis Dancanet left and was replaced by Geoffrey Lauprete. Bazzi, a Citadel Securities veteran, had negotiated a deal to stay with founder Steve Cohen in October following the changes. Building the centralised trading unit to operate alongside Cubist's independent pods was a key initiative when Dancanet joined in 2020, with the firm spending tens of millions to recruit top talent.
Ovid Therapeutics has raised $60 million in a private placement led by Point72, with participation from existing investors including Adage Capital Management, RA Capital Management and Janus Henderson Investors. The financing is expected to close on 19 March 2026. The biopharmaceutical company is selling 19,154,321 shares of common stock at $2.01 per share, plus pre-funded warrants to purchase up to 10,701,710 additional shares at $2.009 each. The warrants have an exercise price of $0.001 per share and are immediately exercisable. Ovid plans to use the proceeds, combined with existing cash and marketable securities, to expand development of OV329, its next-generation GABA-aminotransferase inhibitor, into tuberous sclerosis complex and infantile spasms.